FDA’s aggregate BE for NTIDs: example [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2013-01-13 16:54 (4504 d 23:40 ago) – Posting: # 9834
Views: 16,123

Dear all,

I tried to implement FDA’s aggregate BE according to the warfarin guidance in Phoenix/WinNonlin 6.3. For a discussion see also this thread. In order to demonstrate BE a study has to pass three criteria:
  1. RSABE based on θ=[ln(1.11111)/0.1]2: crit. bound ≤0.
  2. unscaled ABE: 90% CI within 80.00–125.00%.
  3. comparison of σWT with σWR: upper 95% CL of sWT/sWR ≤2.5.
For an example data set (20kB xls) I got:
  1. critbound: -0.0098283 (passed)
  2. CI:         93.90–103.35% (passed)
  3. upper CL:   1.0453 (passed)
Can you check in your installation – or other software – whether I screwed up?*



Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,667 registered users;
136 visitors (0 registered, 136 guests [including 87 identified bots]).
Forum time: 17:35 CEST (Europe/Vienna)

Don’t undertake a project
unless it’s manifestly important
and nearly impossible.    Edwin H. Land

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5